List of Diseases Treated by SCT

• diabetes and its complications
• hormone deficiencies
• early menopause
• male and female infertility
• immune deficiencies
• aging disease
• Spinal cord injuries, Parkinson's& neurological diseases
• Down syndrome genetic diseases birth injuries
• degenerative diseases liver, heart, etc.

Treatment procedure

List of stem cell transplants

How to get SCT treatment

HOME

 Treatment of Degenerative Diseases of Liver and Heart by Stem Cell Transplantation.

1. Cirrhosis of the liver and chronic hepatitis have been treated by stem cell transplantation (SCT) with success for the last four decades (if you click on the above SCT link you will open our homepage where you learn more about this therapy and how to order our stem cell transplants)
    
2. After extensive experimental work, a treatment of heart attack by stem cell transplantation was introduced by cardiologists into clinical practice. 

(biocell@stem-cell-transplantation.com)

There are many German publications to confirm value of stem cell therapy in the treatment of incurable liver diseases. 

Cirrhosis of liver and chronic hepatitis were very common in Germany in 40 - 50 - 60 - ies. This was a result of severe epidemic of viral hepatitis in Germany during WW2 and thereafter.

Since even today there is no effective therapy for damaged liver, stem cell therapy became a treatment of choice for such serious liver diseases.  

Such patients can be helped unless their disease has advanced into the stage of portal hypertension (edema, ascites, bleeding esophageal varices, etc.).

If chronic alcoholism is the cause of liver cirrhosis, stem cell transplantation would be of value only with a total abstinence.

For patients with chronic hepatitis it is mandatory to suppress an inflammatory process in the liver first, by all other therapeutic means. With such approach the success of stem cell transplantation can be unexpectedly high. 

During last two years several patients with recent extensive myocardial infarction were treated by stem cell transplantation in various western European countries with uniformly good results. It is reported in "Handbook of Cardiovascular Cell Transplantation", published in 2004 by Martin Dunitz, a U.K. publisher.

The purpose is to 

• regenerate as many damaged heart muscle fibers as possible, and thereby decrease the size of myocardial scar, as well as
  
  
• stimulate angiogenesis, e.g. forming new blood vessels from the pre-existing ones. 
  

For patients with massive heart attacks it is a matter of life or death, or a matter of debilitating disability versus ability to live reasonably well.

Stem cell transplants have to be implanted also into heart, although not necessarily directly into heart muscle. They can be implanted into re-opened obstructed branch of coronary artery, or into infarcted heart muscle via angiographic approach.

According to U.S. statistics 1.1 million Americans gets heart attack every year.  And there is 4.8. million of patients with congestive heart failure, of which over one half dies within 5 years. 

All such patients should be candidates for stem cell transplantation.

Since 1998 we have made our stem cell transplants available to 

• physicians for treatment of their own patients, but also to
  
  
• patients directly (naturally with physician's prescription),  

with worldwide delivery. 

This was a result of our 25+ years' of research, GMP ('good manufacturing practice'),  and clinical experience with stem cell transplantation in thousands of patients suffering liver cirrhosis, chronic hepatitis, chronic pancreatitis, ulcerative colitis, Crohn's disease, etc.   

The existing treatments of all degenerative diseases suffer from one common problem: no attempt at regeneration of degenerating cells of diseased organs and tissues is made. The sole treatment available to medicine today to directly regenerate cells, tissues and organs is stem cell transplantation. 

Most of known degenerative diseases have been treated with success by stem cell transplantation.

The use of stem cell transplantation as a treatment of above described diseases, can be studied in a textbook of E. Michael Molnar, M.D. "Stem Cell Transplantation, a Textbook of Stem Cell Xeno-Transplantation", published by Medical And Engineering Publishers, Inc., Washington, D.C., in February 2006, the first textbook for medical profession and students in the world about this subject. Click on www.mepublishers.com

(biocell@stem-cell-transplantation.com)

Our know-how, based on 25+ years of experience, permits us to offer you in this web site  

• free advice about the usefulness of stem cell transplantation as a therapy of illness(es) that you, or your loved ones, suffer from, which you could get nowhere else on the Web, (click on "How to get SCT treatment" on the MENU bar, if you wish to learn more about this free service) 
  
  (Please, beware that stem cell transplantation is not a 'wonder' treatment for all diseases known to mankind, and so it may be of no use in your particular case.)

as well as a possibility to

• order stem cell transplants manufactured by our company  for actual patient treatment,
  
  with worldwide delivery.

(Long distance consultation will soon be available via telemedicine link as well.)

Whenever you contact us on this web site in order to 

• get such a free advice via our online questionnaire, 

we will respond promptly.

Besides that we assign each prospective client an ID code, so that there is no need to use the patient's name in future communications, or on vials containing the patient's stem cell transplants. The combined effect of such steps is that sensitive medical data will not get into the wrong hands.